Literature DB >> 3284823

Ectopic expression of the Y (Ley) antigen defined by monoclonal antibody 12-4LE in distal colonic adenocarcinomas.

J Bara1, R Mollicone, E Herrero-Zabaleta, R Gautier, N Daher, R Oriol.   

Abstract

Monoclonal antibody (MAb) 12-4LE reacts specifically with the alpha Fuc(1-2) beta Gal(1-4) [alpha Fuc(1-3)]GlcNAc-R synthetic oligosaccharide and consequently characterizes the Y (Ley) antigen. In normal individuals, this MAb reacts more strongly on samples from blood group O persons, indicating that the Y structure is better recognized when terminal A or B sugars are not added to the Y structure. In fetal and normal adult gastrointestinal tract, this antibody reacts with the epithelium of stomach, small intestine and proximal colon, but not of distal colon. In the adult, cells from the surface epithelium of the gastric, small intestinal and cecal mucosae express the Y antigen according to the secretor phenotype of each individual, thus characterizing the so-called "upward differentiation" pattern. In contrast, mucus cells of the pylorus and duodenal Brünner glands, as well as Paneth cells, always express the Y antigen irrespective of secretor phenotype, thereby characterizing the so-called "downward differentiation" pattern. Proximal fetal colonic mucosa has the same genetic control as the downward differentiation pattern of the adult. Distal fetal colonic mucosa is negative with anti-Y, as in the adult. Y antigen was not expressed in hyperplastic (10 cases), juvenile (5 cases) or adenomatous (43 cases) polyps, except for some spreading villous adenomas in which rare Y-positive foci could be observed but which were not specifically associated with dysplastic glands. Polyps from familiar polyposis did not express this antigen. In adenocarcinomas, the Y antigen was expressed in 41/45 (91%) of distal tumors and 15/35 (43%) of cecal tumors, independently of ABO phenotype. The ectopic expression of this Y antigen on distal colon adenocarcinomas may be a useful tool in the detection of distal colonic carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284823     DOI: 10.1002/ijc.2910410508

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Immunochemical characterization of mucins. Polypeptide (M1) and polysaccharide (A and Leb) antigens.

Authors:  J Bara; R Gautier; J Le Pendu; R Oriol
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

2.  Characterization of the binding specificity of Anguilla anguilla agglutinin (AAA) in comparison to Ulex europaeus agglutinin I (UEA-I).

Authors:  S E Baldus; J Thiele; Y O Park; F G Hanisch; J Bara; R Fischer
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis.

Authors:  F Hallouin; C Goupille; M le Cabellec; J Bara; J le Pendu
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

4.  Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitope.

Authors:  M Schwonzen; R Schmits; S E Baldus; M Vierbuchen; F G Hanisch; M Pfreundschuh; V Diehl; J Bara; G Uhlenbruck
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

5.  Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals.

Authors:  Severine Marionneau; Nathalie Ruvoën; Beatrice Le Moullac-Vaidye; Monique Clement; Anne Cailleau-Thomas; Guillermo Ruiz-Palacois; Pengwei Huang; Xi Jiang; Jacques Le Pendu
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.